The Resona 7 system is the result of leveraging Mindray and ZONARE technologies
Mountain View, Calif. (PRWEB) November 22, 2016
Shenzhen Mindray Bio-Medical Electronics Co.,Ltd. (Mindray), a leading global developer, manufacturer and marketer of medical devices, is introducing its new Resona 7 premium ultrasound system at the annual Radiology Society of North America (RSNA) congress being held in Chicago, IL November 27 – December 2, 2016. Integrating ZONARE’s revolutionary ZONE Sonography® Technology (ZST) with Mindray’s rich repertoire of workflow and user interface advances, the Resona 7 offers premium imaging capabilities with a substantial family of features.
“The Resona 7 system is the result of leveraging Mindray and ZONARE technologies,” said Glen McLaughlin, PhD, president of Mindray/ZONARE and chief product officer, Ultrasound for Mindray. “This powerful combination provides the clinician superb imaging, user interface and workflow solutions. The ergonomics were designed with input from our customers to optimize comfort and maximize patient throughput.”
The system provides crystal clear B-mode imaging capabilities with unrivaled detail resolution and image uniformity across all radiology applications. Ultrasensitive Doppler modes and high-speed digital signal processing are designed to display hemodynamic states from the skin line to depths of up to 40 centimeters without compromising frame rate. An intuitive, customizable gesture-powered touch screen enables logical and efficient workflow and an enhanced user experience.
Designed by users for users, the Resona 7 features a fully customizable multi-gesture touch screen tailored to user needs and workflow. Features include six-way adjustable control panel with electronic height adjustment, a 12.1 inch tilting multi-touch screen and an electronic floating control panel, which moves left/right, up/down and back/forth.
“Coupling premium imaging with advanced workflow features and user-directed ergonomic design, the Resona 7 moves premium level ultrasound imaging into the next generation,” McLaughlin said. “We will continue to expand our core technologies working closely with our valued clinicians and users in support of our mutual goals of providing excellence in patient care.”
Mindray is a leading developer, manufacturer and marketer of medical devices worldwide. Mindray maintains its global headquarters in Shenzhen, China; North American headquarters in Mahwah, New Jersey; and multiple development facilities and offices in major international markets including an ultrasound Innovation Center (ZONARE) in Silicon Valley, CA. Mindray supplies a broad range of products across three primary business segments, patient monitoring and life support, in-vitro diagnostics, and medical imaging systems. For more information, please visit http://www.mindray.com.
ZONARE is a wholly owned subsidiary of Mindray located in Silicon Valley, CA. As a Mindray Center of Innovation, the company is solely dedicated to ultrasound excellence through its innovative, award-winning next generation technology which provides the platform for the company’s Living Technology designed to meet its customers evolving imaging needs. The patented design and ZONE Sonography™ Technology (ZST) architecture of the Z.One PRO and ZS3 platforms deliver high-end image quality and clinical versatility. For more information, please visit http://www.zonare.com